Cargando…
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response
Full-length HER2 oncoprotein and splice variant Delta16 are co-expressed in human breast cancer. We studied their interaction in hybrid transgenic mice bearing human full-length HER2 and Delta16 (F1 HER2/Delta16) in comparison to parental HER2 and Delta16 transgenic mice. Mammary carcinomas onset wa...
Autores principales: | Palladini, Arianna, Nicoletti, Giordano, Lamolinara, Alessia, Dall’Ora, Massimiliano, Balboni, Tania, Ianzano, Marianna L., Laranga, Roberta, Landuzzi, Lorena, Giusti, Veronica, Ceccarelli, Claudio, Santini, Donatella, Taffurelli, Mario, Di Oto, Enrico, Asioli, Sofia, Amici, Augusto, Pupa, Serenella M., De Giovanni, Carla, Tagliabue, Elda, Iezzi, Manuela, Nanni, Patrizia, Lollini, Pier-Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589593/ https://www.ncbi.nlm.nih.gov/pubmed/28903354 http://dx.doi.org/10.18632/oncotarget.17088 |
Ejemplares similares
-
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft
por: Landuzzi, Lorena, et al.
Publicado: (2021) -
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
por: Croci, Stefania, et al.
Publicado: (2015) -
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2
por: De Giovanni, Carla, et al.
Publicado: (2014) -
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas
por: Landuzzi, Lorena, et al.
Publicado: (2014) -
Preclinical Therapy of Disseminated HER-2(+) Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus
por: Nanni, Patrizia, et al.
Publicado: (2013)